CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 710 enrolled
Drug / intervention
Remote patient monitoring (Partnership for the Heart) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00543881
NCT00543881Phase 3Completed

Telemedical Interventional Monitoring in Heart Failure (TIM-HF)

Charite University, Berlin, Germany·interventional·Posted Oct 15, 2007·Updated Dec 21, 2016

In Brief

A Phase 3 clinical trial evaluating Remote patient monitoring (Partnership for the Heart) and Usual care group for Chronic Heart Failure. Completed, enrolled 710 participants across 2 sites.

Detailed Summary

Superiority of additional Remote Patient Monitoring in patients with CHF In comparison to usual care in terms of: * reduction of mortality rate * reduction of hospitalizations * increasement of patients' quality of life

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 15, 2007
Enrollment StartJan 1, 2008
Primary CompletionJul 1, 2010
Study CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 18.7 years ago

Interventions

Remote patient monitoring (Partnership for the Heart)device

Guideline-based care in heart failure (NYHA II-III) including at least 5 scheduled doctor's visits plus daily monitoring of ECG, weight, blood pressure, self-report of health status, weekly monitoring of physical fitness

Usual care groupdevice

Guideline-based care in heart failure (NYHA II-III) including at least 5 scheduled doctor's visits